3 June 2021
Multicenter interventional post-registration phase IV clinical trial for the evaluation of the efficacy and safety of COVID-19 vaccines – CoVigi, is already underway. Interest in participating in the study exceeded original expectations. The original estimate of 50 patients per month was ahead of the reality, and after 9 weeks of recruitment, the study gained an average of 44 patients per week. You can read all information about the study at www.covivac.cz/covigi (only in Czech language).